The Clonogenic Precursor Cell in Multiple Myeloma

References

• Mellstedt H., Holm G., Bjorkholm M. Multiple myeloma. Waldenstrom's macroglobulinemia, and benign monoclonal gammopathy. Adv. Cancer Res. 1984; 41: 257–289
   PubMed Web of Science ®Google Scholar
• Kyle R.A. Diagnostic criteria of multiple myeloma. Hematol/Oncol Clinics N. Amer. 1992; 6: 347–358
   PubMed Web of Science ®Google Scholar
• Kyle R.A. Malignant B-cell monoclonal gammopathies. Monoclonal gammapathies- Clinical significance mid basic mechanisms, J. Radl, W. Hijmans, B. Van. Camp. Eurage, Rijswijk, The Netherlands 1985; Vol 5.: 15–23
   Google Scholar
• Greipp P.R., Kyle R.A. Clinical, morphological and cell kinetic difference among multiple myeloma. monoclonal gammopxthy of undetermined significance, and smoldering multiple myeloma. Blood 1983; 62: 166–171
   PubMed Web of Science ®Google Scholar
• Greipp P.R., Raymond N.M., Kyle R.A., O'Fallon W.M. Multiple myeloma: Significance of plasmablastic subtype in morphological classification. Blood 1985; 65: 305–310
   PubMed Web of Science ®Google Scholar
• Malavasi F., Calligaris-Cappio F., Milanese C., Dellabona P., Richiardi P., Carbonara A.O. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum. Immunol. 1984; 9: 9–20
   PubMed Web of Science ®Google Scholar
• Anderson K.C., Park E.K., Bates M.P., Leonard R.C.F., Hardy R., Schlossman S.F., Nadler L.M. Antigens on human plasma cells identified by monoclonal antibodies. J. Immunol. 1983; 130: 1132–1138
   PubMed Web of Science ®Google Scholar
• Gonchoroff N.J., Katzmann J.A., Carton Ruiz- J.P., Arguelles G.J., Eilers C.R., Greipp P.R., Kyle R.A. A monoclonal antibody reactive with a subset of human plasma cells. Br. J. Haematol. 1986; 62: 619–430
   PubMed Web of Science ®Google Scholar
• Jackcon N, Ling N.R., Ball J., Bromidge E., Nathan P.D., Franklin I.M. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd international workshop on human leucocyte differentiation antigens. Clin. Exp. Immunol. 1988; 72: 351–356
   PubMed Web of Science ®Google Scholar
• Epstein J., Barlogie B., Kodzman J., Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood. 1988; 71: 861–865
   PubMed Web of Science ®Google Scholar
• Chan C.S.P., Wormsley S.B., Pierce L.E., Peter J.B., Schechter G.P. B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy. Am. J. Hematol. 1990; 33: 101–109
   PubMed Web of Science ®Google Scholar
• Hamilton M.S., Ball J., Bromidge E., Franklin I.M. Surface antigen expression of human neoplastic plasma cell includes molecules associated with lymphocytes recirculation and adhesion. Birt. J. Haematol. 1991; 78: 60–65
   PubMed Web of Science ®Google Scholar
• San Miguel J.F., Gonzales M., Gascon A., More M.J., Hernandez J.M., Ortega F., Jimenez R., Guerras L., Romera M., Casanova F. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Brit J. Haematol. 1991; 77: 185–190
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Fried J., Perez A.G., Scheinberg D.A., Atzpodien J., Wang C.Y., Wisniewolsky R., Clarkson B.D. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Act. Haematol. 1990; 83: 123–129
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Gotoh H., Ashihara E., Oku N., InabaMurakami T.S, Itoh K., Ura Y., Nakagawa M., Fujita N. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia. Am. J. Hematol. 1992; 39: 159–102
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H., He X.Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl, J. Med 1990; 322: 664–668
   PubMed Web of Science ®Google Scholar
• van Riet I., De Waele M., Remels L., Lacor P., Schots R., van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 arid CD29) by myeloma plasma cells. Brit. J. Haematol. 1991; 79: 421–427
   PubMed Web of Science ®Google Scholar
• Ahsmann E.J.M., Lokhorst H.M., Dekker A.W., Bloem A.C. Lymphocyte function-associated antigen-1 expression on plasma cell correlates with tumour growth in multiple myeloma. Blood 1992; 79: 2068–2075
   PubMed Web of Science ®Google Scholar
• van Camp R., Durie B.G.M., Spier C., De Waele M., van Riet I., Vela E., Frutiger Y., Kichter L., Crogan T.M. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood. 1990; 76: 377–382
   PubMed Web of Science ®Google Scholar
• van Riet I., van Camp B. The involvement of adhesion molecules in, the biology of multiple myeloma. Leukemia and lymphoma 1993; 9: 141–452
   PubMed Web of Science ®Google Scholar
• Uckun F.M. Regulation of B-cell ontogeny. Blood. 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Gallagher R.B., Osmond D.G. To B or not to B: that is the question. Immunol Today 1991; 12: 1–3
   PubMedGoogle Scholar
• MacLennan I.C.M., Gray D. Antigen-driven selection of virgin and memory R cells. Immunol. Rev. 1986; 91: 61–85
   PubMed Web of Science ®Google Scholar
• MacLennan I.C.M., Lieu Y.J., Oldfield S., Zhang J., Lane P.J.L. The evolution (of B-cell clones. Curr. Topics Microbiol. Immunol. 1990; 16(9)37–60
   Google Scholar
• Ho F., Lortan J E., MacLennan I.C.M., Khan M. Distinct short-lived and long-lived antibody producing cell populations. Eur. J. Immunol. 1986; 16: 1297–1301
   PubMed Web of Science ®Google Scholar
• Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575–581
   PubMed Web of Science ®Google Scholar
• Manser T. Evolution of antibody structure during the immune response: the differentiative potential of a single B lymphocyte. J. Exp. Med. 1989; 170: 1211–1230
   PubMed Web of Science ®Google Scholar
• Liu Y.-J., Joahua D.E., Williams G.T., Smith C.A., Gordon J., MacLennan I.C.M. The mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• MacLennan I.C.M. Germinal Centers. Annu. Rev. Immunol. 1994; 12: 117–139
   PubMed Web of Science ®Google Scholar
• Benner R., Hijmans W., Haaijman J.J. The bone marrow: the major source of serum immunoglobulins. but still a neglected site of antibody formation. Clin. Exp. Immunol. 1981; 46: 1–8
   PubMed Web of Science ®Google Scholar
• Mellstedt H., Hammerstian S., Holm G. Monoclonal lymphocyte /population in human plasma cell myeloma. Clin. Exp. Immunol 1974; 17: 371–384
   PubMed Web of Science ®Google Scholar
• Kubagawa W., Vogler J.D., Capra M.E., Lawton A.R., Cooper M.D. Studies on the clonal origin of multiple myeloma. J. Exp. Med. 1979; 150: 792–807
   PubMed Web of Science ®Google Scholar
• van Acker A., Conte F., Hullin N., Urhain J. Idiotypic studies cm multiple myeloma. Eur. J. Cancer. 1979; 15: 627–635
   PubMed Web of Science ®Google Scholar
• Camp Van, Reynaert B.P., Broudtaerts L. Studies on the origin of the precursor cell in multiple myeoma, Waldenström macroglobulinaemia and benign monoclonal gammopathy. Clin. Exp. Immunol. 1981; 44: 82–89
   PubMedGoogle Scholar
• Bast E. J. E. G., van Camp B., Reynaert P., Wieringa G., Ballicux R.E. Idiotypic peripheral blood lymphocytes in monoclonal gammopathy. Clin. Exp. Immunol. 1982; 47: 677–682
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Tesio L., Pizzolo G., Malavasi F., Chilosi M., Campana D., van Camp B., Janoshy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin., Invest. 1985; 76: 1743–1251
   Web of Science ®Google Scholar
• Bagg Becker A., Bezwada P.W., van Rensburg L., Mendelow H. Circulating monotypic B-cells inmultiple myeloma: associations with lambda paraproteins. Brit. J Haematol 1989; 72: 107–177
   Google Scholar
• Hoover R.G., Hiekman S., Gebel H.M., Rebbe N., Lynch R.G. Expansion ot Fe receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma. J. Clin. Invest. 1981; 67: 308–311
   PubMed Web of Science ®Google Scholar
• Kiyotaki M., Cooper M.D., Bertoli R.F., Kubagawa H. Monoclonal anti-Id antibodies react with varying pro-portiopns of human B lineage cells. J. Immunol. 1987; 138: 4150–4158
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichtenstein A. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• van Riet I., Heirman C., Lacor P., De Waele M., Thielemans K., van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Brit, J. Haematol. 1989; 73: 289–295
   PubMed Web of Science ®Google Scholar
• Jensen G.S., Mant M.J., Belch A.J., Berenson J.R., Ruether B.A., Pilarski L.M. Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78: 711–719
   PubMed Web of Science ®Google Scholar
• van Dyk L., Meek K. Assembly of IgH CDR3: Mechanism, regulation and influenze on antibody. Int. Rev. Immunol. 1992; 8: 123–133
   PubMedGoogle Scholar
• Alzari P.M., Poljak R.J. Three dimensial sstructute of antibodies. Annu. Rev. Immunol. 1988; 6: 555–580
   PubMed Web of Science ®Google Scholar
• Foote J., Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Bid 1992; 22: 487–499
   Web of Science ®Google Scholar
• Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 1991; 147: 1720–1729
   PubMed Web of Science ®Google Scholar
• Yamada M., Wasserman R., Reichard B.A., Shane S., Caton A.J., Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 1991; 173: 395–407
   PubMed Web of Science ®Google Scholar
• Meek K. Analysis of junctional diversity during B lymphocyte development. Science 1990; 250: 820–823
   PubMed Web of Science ®Google Scholar
• Wasserman R., Galili N., Ito Y., Reichard B.A., Shane S., Rovera G. Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event. J. Exp. Med. 1992; 176: 1577–1581
   PubMed Web of Science ®Google Scholar
• Rajewski K., Forster I., Cumano A. Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 1987; 238: 1088–1094
   PubMed Web of Science ®Google Scholar
• Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 1987; 96: 23–41
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J.D. Detection of immunoglobulin gene rearrangement in B lymphoid malignancies. Br. J. Haematol. 1990; 74: 251–256
   PubMed Web of Science ®Google Scholar
• Trainor K.J., Brisco M.J., Wan J.H., Neoh S., Grist S., Morley A.A. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991; 78: 192–196
   PubMed Web of Science ®Google Scholar
• McCarthy K.P., Sloane J.P., Wiedemann L.M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J. Clin. Pathol. 1990; 43: 429–432
   PubMed Web of Science ®Google Scholar
• Deane M., McCarthy K.P., Wiedemann L.M., Norton J.D. An improved method for detection of B-lymphoid clonality by the polymerase chain reaction. Leukemia 1991; 5: 726–730
   PubMed Web of Science ®Google Scholar
• Bakkus M.H.C., Heirman C., van Riet I., van Camp B., Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326–2335
   PubMed Web of Science ®Google Scholar
• Wysocki L., Manser T., Gefter M.L. Somatic evolution of variable region structures during an immune reponse. Proc. Nd. Acad. Sci. USA 1986; 83: 1847–1851
   PubMed Web of Science ®Google Scholar
• Kocks C., Rajewsky K. Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc. Natl. Acad. Sci. USA 1988; 85: 8206–8210
   PubMed Web of Science ®Google Scholar
• Sharon J., Gefter M.L., Wysocki L.J., Margolies M.N. Recurrent somatic mutations inmouse antibosies to p-azophenylarsonate increase affinity for hapten. J. Immunol. 1989; 142: 596–601
   PubMed Web of Science ®Google Scholar
• Shlomchik M.J., Marshak-Rothstein A., Wolfowicz C.B., Rothstein T.L., Weigert M.G. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987; 328: 805–811
   PubMed Web of Science ®Google Scholar
• Sahota S., Hamblin T., Oscier D.G., Stevenson F. Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia 1994; 8
   PubMed Web of Science ®Google Scholar
• Ralph Q.M., Brisco M.J., Joshua D.E., Brown R., Gibson J., Morley A.A. Advancement of Multiple Myeloma from Diagnosis Through Plateau Phase to Progression Does Not Involve a New B-Cell Clone—p-Evidence from the Ig Heavy Chain Gene. Blood 1993; 82(1): 202–206
   Web of Science ®Google Scholar
• Takishita M., Kosaka M., Goto T., Saito S. Cellular origin and extend of clonal involvement in multiple myeloma: genetic and phenotypic studies. Brit, J. Haematol. 1994; 87: 735–742
   PubMed Web of Science ®Google Scholar
• Billadeau D., Quam L., Thomas W., Kay N., Greipp P., Kyle R., Oken M.M., van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma. Blood 1992; 80: 1818–1824
   PubMed Web of Science ®Google Scholar
• Billadeau D., Ahmann G., Greipp P., van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med. 1993; 178: 1023–1031
   PubMed Web of Science ®Google Scholar
• Billadeau D., Blackstadt M., Greipp P., Kyle R.A., Oken M.M., Kay N., van Ness B. Analysis of B-lymphoid malignancies using allele-specitipolymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 1991; 78: 3021–3029
   PubMed Web of Science ®Google Scholar
• Corradini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cp sequence in IgC and IgA secreting multiple myelomas. J. Exp. Med. 1993; 178: 1091–1096
   PubMed Web of Science ®Google Scholar
• Corradini P., Voena C., Omede P., Astolfi M., Boccadoro M., Dalla-Favera R., Pileri A. Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia 1993; 7: 1879–1882
   PubMed Web of Science ®Google Scholar
• Bakkus M.H.C., van Riet I., van Camp B., Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Brit, J. Haematol. 1994; 87: 68–74
   PubMed Web of Science ®Google Scholar
• Bakkus M.H.C., van Riet I., Jochmans K., Lacor P., van Camp B., Thielemans K. Detection of residual multiple myeloma cells by PCR in blood stem cell concentrates after GM-CSF treatment. Monoclonal gammapathies III–Clinical significance and basic mechanisms, J. Radl, B. Van. Camp. Eurage, LeidenThe Netherlands 1991; 183–186
   Google Scholar
• Wagner S.D., Martinelli V., Luzzatto L. Similar patterns of VK gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, waldenstrôm's macroglobulinemia, and myeloma. Blood 1994; 83: 3647–3653
   PubMed Web of Science ®Google Scholar
• Shlomchik M.J., Aucoin A.H., Pisetsky D.S., Weigert M.G. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. 1987; 84: 9150–9154
   PubMed Web of Science ®Google Scholar
• Levy R., Levy S., Clearly M.L., Carroll W., Kon S., Bird J., Sklar J. Somatic mutation in human B-cell tumors. Immunol. Rev. 1987; 96: 43–58
   PubMed Web of Science ®Google Scholar
• Ebeling S.B., Schutte M.E.M., Logtenberg T. Evidence that a large fraction of human CD5+ and CD5- IgM-bearing B cells in adult peripheral lymphoid tissues is ligand selected. J. Immunol. 1993; 151: 6891–6899
   PubMedGoogle Scholar
• van Es J.H., Gmelig Meyling F.H.J., Logtenberg T. High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire. Eur. J. (Immunol 1992; 22: 2761–2764
   PubMed Web of Science ®Google Scholar
• österborg A., Mellstedt H. Monoclonal and biclonal immunoglobulin-producing disorders. Eur. J. Haematol Suppl, 51 1989; 43: 11–18
   Web of Science ®Google Scholar
• ChenMi Y., Word C.J., Jones S., Uhr J.W., Tucker P.W., Vitetta E.S. Double isotype production by a neoplastic B cell line I. cellular and biochemical characterization of a variant of BCLI that expresses and secretes both IgM and IgGI. J Exp Med. 1986; 164: 548–561
   PubMed Web of Science ®Google Scholar
• Akahori Y., Kurosawa Y., Kamachi Y., Torii S., Matsuoka H. Presence of immunoglobulin (Ig) M and IgG double isotype-bearing cells and defect of switch recombination in hyper IgM immunodeficiency. J. Clin. Invest. 1990; 85: 1722–1727
   PubMed Web of Science ®Google Scholar
• Kunimoto D.Y., Sneller M.C., Claflin L., Mushinski J.F., Strober W. Molecular analysis of double isotype expression in IgA Switching. J. Immunol. 1993; 150: 1338–1347
   PubMed Web of Science ®Google Scholar